Third Affiliated Hospital, Sun Yat-Sen University: Hepatitis, Chronic trials

The registry lists 22 Hepatitis, Chronic studies with Third Affiliated Hospital, Sun Yat-Sen University as lead sponsor. 1 are open to participants now and 0 have results posted.

Early Phase 1 2Phase 1 2Phase 2 2Phase 3 2Phase 4 7No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Therapeutic Effects and Long-term Follow-up After Ending Nucleos(t)Ide Analogs Therapy in Chronic Hepatitis bRecruitingNCT02883647
• Effect of Serum Vitamin D Level on the Efficacy of Peg-interferon Treatment in CHBCompletedNCT05753280Phase 4
• LDT Combined With TDF to Improve EGFR Decreasing in Patients With Chronic Hepatitis B Treated With TDFStatus unknownNCT04643990
• Efficacy and Safety of TAF in Pregnant Women With Chronic Hepatitis B InfectionStatus unknownNCT04507607Early Phase 1
• Three Types of Nucleotide/Nucleoside Analogues Therapy in Patients With Chronic Hepatitis bStatus unknownNCT04195074Not applicable
• Real-world Effectiveness and Safety of Treatment With DAAs in Patients With CHC(Chronic Hepatitis C)Status unknownNCT03887637
• The Optimizing Treatment of Peginterferon Alpha in Chronic Hepatitis B Patients With Low Level HBsAgStatus unknownNCT03801538Phase 4
• Optimal Treatment for Poor Efficacy of Entecavir in Chronic Hepatitis B PatientsStatus unknownNCT03733652Not applicable
• The Relationship Between MDSCs and NK Cells Activity of CHC Patient Treated by DAAsCompletedNCT03188276Early Phase 1
• Dynamic Changes of Monocytes and NK Cells of CHC Patient Treated by DAAsCompletedNCT03063723
• Peginterferon Alfa-2b Treatment in HBeAg(+) Chronic Hepatitis b Patients Based on Interferon Gene Mutation and Receptor DetectionStatus unknownNCT02973646Phase 4
• HBsAg Loss/Seroconversion in Low Replicative Chronic Hepatitis B Virus(HBV) Infection PatientsStatus unknownNCT02908763Phase 4
• The Optimizing Treatment of Peginterferon (PEG IFN) Alpha in Chronic Hepatitis B Virus Patients With Low Level HBsAgStatus unknownNCT02893124Phase 4
• The Optimizing Treatment of PegIFN Alfa in HBeAg-negative CHB Patients With Low Level HBsAgStatus unknownNCT02838810Phase 4
• Follow-up Strategy of Chronic Hepatitis B for Early Detection and Diagnosis of Hepatocellular Carcinoma: A Randomized Control TrialStatus unknownNCT02817685
• The Optimizing Treatment of PegIFN Alfa in HBeAg-negative CHB Patients With Low Level HBsAgStatus unknownNCT02745704Phase 4
• A Clinical Trial on Hepatitis B Vaccine Activated-Dendritic Cells Combined With Anti-HBV Drugs in CHBStatus unknownNCT02615639Phase 1/2
• Accuracy of RTE for Evaluating Hepatic Fibrosis in Chronic Hepatitis: a Prospective Multicenter StudyStatus unknownNCT02143180
• A Clinical Trial on HB-Vac Activated-DCs Combined With Peg-IFN or NAs in CHBCompletedNCT01935635Phase 1/2
• Efficacy and Safety of Peginterferon a-2a in Patients of Chronic Hepatitis B With Spontaneous Decline of HBV DNACompletedNCT01892241Phase 3
• Efficacy of Short-term Immunosuppressive Therapy and Anti-allergenic Therapy in Severe Acute Exacerbation of Chronic Hepatitis BStatus unknownNCT01627236Not applicable
• Response to Pegylated Interferon and Ribavirin in Chinese Patients With Chronic Hepatitis C Genotypes 1 Versus 2/3 Versus 6CompletedNCT01433887Phase 3